Poulton Jeffrey V. Insider Trades

Insider Trading History

Track insider trading activity for Poulton Jeffrey V.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CervoMed
CervoMed CRVO
Director
Holding Value $30.3k 8,150 shares
Last Trade
Jun 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.7k 8,150 shares
$2.91
$3.72
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $18.5M 64,159 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$797k 2,468 shares
$323.08
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $19.1M 66,414 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$723k 2,206 shares
$327.65
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $19.2M 66,479 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.96M 15,249 shares
$325.07
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Feb 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$635k 1,908 shares
$332.76
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $17.8M 61,710 shares
Last Trade
Feb 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$635k 1,908 shares
$332.76
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $17.2M 59,802 shares
Last Trade
Feb 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$695k 2,242 shares
$310.08
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $17.9M 62,044 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 4,579 shares
$308.48
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $17.3M 60,173 shares
Last Trade
Jan 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.01M 2,780 shares
$362.85
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $17.4M 60,245 shares
Last Trade
Jan 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.47M 6,193 shares
$398.29
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $16.6M 57,723 shares
Last Trade
Oct 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.73M 3,821 shares
$452.05
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $15.1M 52,332 shares
Last Trade
Aug 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.03M 2,274 shares
$453.27
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $15.1M 52,395 shares
Last Trade
Aug 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.08M 4,644 shares
$448.91
$288.18
CervoMed
CervoMed CRVO
Director
Holding Value $30.1k 8,100 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.8k 8,100 shares
$6.52
$3.72
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $14M 48,665 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$308k 1,264 shares
$243.78
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $14.1M 49,015 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.39M 9,800 shares
$243.53
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $9.99M 34,652 shares
Last Trade
Feb 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$192k 796 shares
$241.70
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $10M 34,694 shares
Last Trade
Feb 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$452k 1,908 shares
$237.10
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $550k 1,908 shares
Last Trade
Feb 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$452k 1,908 shares
$237.10
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Evp, Chief Financial Officer
Holding Value $9.66M 33,536 shares
Last Trade
Feb 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$247k 967 shares
$255.16
$288.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up